Journal of Affective Disorders
Volume 74, Issue 1 , Pages 67-83 , March 2003

Hormones and mood: from menarche to menopause and beyond

  • Meir Steiner

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-905-522-1155x3605; fax: +1-905-521-6098.
    • ,
  • Edward Dunn

      Affiliations

    • Dr. Dunn is now with the Centre for Addiction and Mental Health, Toronto, Ontario.
    • ,
  • Leslie Born

Received 11 June 2001 ,Accepted 6 July 2001.

References 

  1. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol: a preliminary study. J. Clin. Psychiatry. 2001;62:332–336
  2. American Psychiatric Association. In: 4th Edition. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994;p. 717–718
  3. American Psychiatric Association. In: 4th Edition. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994;p. 386–387
  4. Anderson E, Hamburger S, Liu JH, Rebar RW. Characteristics of menopausal women seeking assistance. Am. J. Obstet. Gynecol. 1987;156:428–433
  5. Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol. Med. 1998;28:51–61
  6. Angst J, Sellaro R, Merikangas KR, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr. Scand. 2001;104:110–116
  7. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. Br. Med. J. 1997;314:932–936
  8. Armitage R, Emslie GJ, Hoffmann RF, Rintelmann J, Rush JA. Delta sleep EEG in depressed adolescent females and healthy controls. J. Affect. Disord. 2001;63:139–148
  9. Ashby CR, Carr LA, Cook CL, Steptoe MM, Franks DD. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity on premenstrual syndrome. Biol. Psychiatry. 1988;24:225–233
  10. Avis NE, McKinlay SM. A longitudinal analysis of women’s attitudes toward the menopause: results from the Massachusetts Women’s Health Study. Maturitas. 1991;13:65–79
  11. Bancroft J, Cook A. The neuroendocrine response to d-fenfluramine in women with premenstrual depression. J. Affect. Disord. 1995;36:57–64
  12. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G. Blunting of neuroendocrine responses to infusion of l-tryptophan in women with perimenstrual mood change. Psychol. Med. 1991;21:305–312
  13. Best NR, Wiley M, Stump K, Elliott JM, Cowen PJ. Binding of tritiated yohimbine to platelets in women with maternity blues. Psychol. Med. 1988;18:837–842
  14. Bicikova M, Dibbelt L, Hill M, Hampl R, Starka L. Allopregnanolone in women with premenstrual syndrome. Horm. Metab. Res. 1998;30:227–230
  15. Biegon A, McEwen BS. Modulation by estradiol of serotonin receptors in brain. J. Neurosci. 1982;2:199–205
  16. Bloch M, Schmidt PJ, Su TP, Tobin MB, Rubinow DR. Pituitary–adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol. Psychiatry. 1998;43:897–903
  17. Bojlen K, Bentzen MW. Seasonal variation in the occurrence of menarche. Dan. Med. Bull. 1974;21:161–168
  18. Brann DW, Hendry LB, Mahesh VB. Emerging diversities in the mechanism of action of steroid hormones. J. Steroid Biochem. Mol. Biol. 1995;52:113–133
  19. Brockington IF, Winokur G, Dean C. Puerperal psychosis. In:  Brockington IF,  Kumar R editor. Motherhood and Mental Illness. London: Academic Press; 1982;p. 37–69
  20. Burnet RB, Radden HS, Easterbrook EG, McKinnon RA. Premenstrual syndrome and spironolactone. Aust. NZ J. Obstet. Gynaecol. 1991;31:366–368
  21. Carothers AD, Murray L. Estimating psychiatric morbidity by logistic regression: application to post-natal depression in a community sample. Psychol. Med. 1990;20:695–702
  22. Caspi A, Moffitt TE. Individual differences are accentuated during periods of social change: the sample case of girls at puberty. J. Pers. Soc. Psychol. 1991;61:157–168
  23. Casson P, Hahn PM, Van Vugt DA, Reid RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am. J. Obstet. Gynecol. 1990;162:99–105
  24. Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, et al. Continued breast cancer risk in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res. Treat. 2000;65:125–134
  25. Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. J. Am. Med. Assoc. 1992;267:1244–1252
  26. Cizza G, Gold PW, Chrousos GP. High dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression. J. Clin. Endocrinol. Metab. 1997;82:704
  27. Cohen IR, Wise PM. Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats. Endocrinology. 1988;122:2619–2625
  28. Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF. Postpartum prophylaxis for women with bipolar disorder. Am. J. Psychiatry. 1995;152:1641–1645
  29. Cohen P, Cohen J, Kasen S, Velez CN, Hartmark C, Johnson J, et al. An epidemiological study of disorders in late childhood and adolescence. I. Age- and gender-specific prevalence. J. Child Psychol. Psychiatry. 1993;34:851–867
  30. Cooper PJ, Murray L. Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. Br. J. Psychiatry. 1995;166:191–195
  31. Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol. Psychiatry. 1999;46:182–188
  32. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br. J. Psychiatry. 1993;163:27–31
  33. Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, et al. Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World J. Urol. 1995;13:285–289
  34. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 1997;337:1641–1647
  35. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol. 1991;78:991–995
  36. Dorn LD, Chrousos GP. The neurobiology of stress: understanding regulation of affect during female biological transitions. Semin. Reprod. Endocrinol. 1997;15:19–35
  37. Dougherty DM, Bjork JM, Moeller FG, Swann AC. The influence of menstrual-cycle phase on the relationship between testosterone and aggression. Physiol. Behav. 1997;62:431–435
  38. Dunn E, Macdougall M, Coote M, Steiner M. Biochemical correlates of symptoms associated with premenstrual dysphoric disorder. Arch. Womens Ment. Health. 2001;3(Suppl. 2):1
  39. Dunn EJ, Steiner M. The functional neurochemistry of mood disorders in women. In:  Steiner M,  Yonkers KA,  Eriksson E editor. Mood Disorders in Women. London: Martin Dunitz; 2000;p. 71–82
  40. Ehlers CL, Frank E, Kupfer DJ. Social zeitgebers and biological rhythms. Arch. Gen. Psychiatry. 1988;45:948–952
  41. Eriksson E, Sundblad C, Landen M, Steiner M. Behavioural effects of androgens in women. In:  Steiner M,  Yonkers KA,  Eriksson E editor. Mood Disorders in Women. London: Martin Dunitz; 2000;p. 233–246
  42. Eriksson E, Sundblad C, Lisjo P, Modigh K, Andersch B. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology. 1992;17:195–204
  43. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell. Mol. Neurobiol. 1996;16:325–344
  44. FitzGerald M, Malone KM, Li S, Harrison WM, McBride PA, Endicott J, et al. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am. J. Psychiatry. 1997;154:556–558
  45. Fleming AS, Corter C. Factors influencing maternal responsiveness in humans: usefulness of an animal model. Psychoneuroendocrinology. 1988;13:189–212
  46. Fleming AS, Corter C, Steiner M. Sensory and hormonal control of maternal behavior in rat and human mothers. In:  Pryce CR,  Martin RD,  Skuse D editor. Motherhood in Human and Nonhuman Primates. Karger: Basel; 1995;p. 106–114
  47. Fleming AS, Steiner M, Anderson V. Hormonal and attitudinal correlates of maternal behaviour during the early postpartum period in first-time mothers. J. Reprod. Infant Psychol. 1987;5:193–205
  48. Freedman RR. Hot flashes revisited. Menopause. 2000;7:3–4
  49. Freeman EW, Rickels K, Sondheimer SJ. Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents. J. Psychosom. Obstet. Gynaecol. 1993;14:41–50
  50. Freeman EW, Sondheimer S, Weinbaum PJ, Rickels K. Evaluating premenstrual symptoms in medical practice. Obstet. Gynecol. 1985;65:500–505
  51. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog. Neurobiol. 2001;63:29–60
  52. Glaser J, Russel VA, de Villiers AS, Searson JA, Taljaard JJ. Rat brain monoamine and serotonin S2 receptor changes during pregnancy. Neurochem. Res. 1990;15:949–956
  53. Golub S, Harrington DM. Premenstrual and menstrual mood changes in adolescent women. J. Pers. Soc. Psychol. 1981;41:961–965
  54. Gregoire AJP, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933
  55. Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet. Gynecol. 1996;88:437–442
  56. Halbreich U, Rojansky N, Palter S, Tworek H, Hissen P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatry. 1995;37:434–441
  57. Hammarback S, Bäckström T, Holst J, von Schoultz B, Lyrenas S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen–progestagen postmenopausal replacement therapy. Acta Obstet. Gynecol. Scand. 1985;64:393–397
  58. Hankin BL, Abramson LY, Moffitt TE, Silva PA, McGee R, Angell KE. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J. Abnorm. Psychol. 1998;107:128–140
  59. Hannah P, Adams D, Glover V, Sandler M. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria. J. Psychiatr. Res. 1992;26:69–75
  60. Harris B, Lovett L, Newcombe RG, Read GF, Walker R, Riad-Fahmy D. Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. Br. Med. J. 1994;308:949–953
  61. Harris B, Othman S, Davies JA, Weppner GJ, Richards CJ, Newcombe RG, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. Br. Med. J. 1992;305:152–156
  62. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br. J. Psychiatry. 1994;164:513–516
  63. Heidrich A, Schleyer M, Spingler H, Albert P, Knoche M, Fritze J, et al. Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J. Affect. Disord. 1994;30:93–98
  64. Henderson AF, Gregoire AJ, Kumar RD, Studd JW. Treatment of severe postnatal depression with estradiol skin patches. Lancet. 1991;338:816–817
  65. Herbison AE, Horvath TL, Naftolin F, Leranth C. Distribution of estrogen receptor-immunoreactive cells in monkey hypothalamus: relationship to neurones containing luteinizing hormone-releasing hormone and tyrosine hydroxylase. Neuroendocrinology. 1995;61:1–10
  66. Ho H, Olsson M, Westberg L, Melke J, Eriksson E. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?. Neuropsychopharmacology. 2001;24:502–510
  67. Hughes CW, Petty F, Sheikha S, Kramer GL. Whole-blood serotonin in children and adolescents with mood and behavior disorders. Psychiatry Res. 1996;65:79–95
  68. Johnson SR. The epidemiology and social impact of premenstrual symptoms. Clin. Obstet. Gynecol. 1987;30:367–376
  69. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behaviour. J. Reprod. Med. 1988;33:340–346
  70. Katona CLE, Theodorou AE, Missouris CG, Bourke MP, Horton RW, Moncrieff D, et al. Platelet 3H-imipramine binding in pregnancy and the puerperium. Psychiatry Res. 1985;14:33–37
  71. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517–1521
  72. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br. J. Psychiatry. 1987;150:662–673
  73. Kendler KS, Karkowski LM, Corey LA, Neale MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am. J. Psychiatry. 1998;155:1234–1240
  74. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the national comorbidity survey I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 1993;29:85–96
  75. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress. Anxiety. 1998;7:3–14
  76. Keverne EB, Kendrick KM. Maternal behaviour in sheep and its neuroendocrine regulation. Acta Paediatr. Suppl. 1994;397:47–56
  77. Kim J, Alexander C, Korst L, Agarwal S. Effects of breastfeeding on hypoestrogenic symptoms in postpartum women. Obstet. Gynecol. 2000;95(Suppl. 4):65S
  78. Korzekwa MI, Lamont JA, Steiner M. Late luteal phase dysphoric disorder and the thyroid axis revisited. J. Clin. Endocrinol. Metab. 1996;81:2280–2284
  79. Ladisich W. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes. Psychoneuroendocrinology. 1977;2:257–266
  80. Lauber AH, Whalen RE. Muscarinic cholinergic modulation of hypothalamic estrogen binding sites. Brain Res. 1988;443:21–26
  81. Lewinsohn PM, Rhode P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors and clinical implications. Clin. Psychol. Rev. 1998;18:765–794
  82. Lock M. Menopause in cultural context. Exp. Gerontol. 1994;29:307–317
  83. Luine VN, Khylchevskaya RI, McEwen BS. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975;86:293–306
  84. Maggi A, Perez J. Role of female gonadal hormones in the CNS: clinical and experimental aspects. Life Sci. 1985;37:893–906
  85. Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrouses GP. Hypothalamic corticotropin-releasing hormone suppression during the post-partum period: implications for the increase of psychiatric manifestations at this time. J. Clin. Endocrinol. Metab. 1996;81:1912–1917
  86. Mani SK, Blaustein JD, O’Malley BW. Progesterone receptor function from a behavioral perspective. Horm. Behav. 1997;31:244–255
  87. McEwen BS. Genomic regulation of sexual behavior. J. Steroid Biochem. 1988;30:179–183
  88. Menkes DB, Coates DC, Fawcett JP. Acute tryptophan depletion aggravates premenstrual syndrome. J. Affect. Disord. 1994;32:37–44
  89. Millis JB, Kornblith PR. Fragile beginnings: identification and treatment of postpartum disorders. Health Soc. Work. 1992;17:192–199
  90. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women’s Health Study. Maturitas. 1996;25:1–10
  91. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, et al. Allopregnanolone concentrations and premenstrual syndrome. Eur. J. Endocrinol. 2000;142:269–273
  92. Moss RL, Gu Q, Wong M. Estrogen: nontranscriptional signaling pathway. Recent Prog. Horm. Res. 1997;52:33–68 discussion 68–69
  93. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. J. Am. Med. Assoc. 2000;283:1007–1015
  94. Murray D, Cox JL, Chapman G, Jones P. Childbirth: life event or start of a long-term difficulty? Further data on the Stoke-on-Trent controlled study of postnatal depression. Br. J. Psychiatry. 1995;166:595–600
  95. Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H. Association of diet and other lifestyle with onset of menopause in Japanese women. Maturitas. 1998;29:105–113
  96. Nilsen J, Mor G, Naftolin F. Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause. 1998;5:211–216
  97. Nolen-Hoeksema S, Girgus JS. The emergence of gender differences in depression during adolescence. Psychol. Bull. 1994;115:424–443
  98. O’Brien PMS, Abukhalil IEH, Henshaw C. Premenstrual syndrome. Curr. Obstet. Gynecol. 1995;5:30–37
  99. O’Brien PMS, Pitt B. Hormonal theories and therapy for postnatal depression. In:  Cox JL,  Holden J editor. Perinatal Psychiatry: Use and Misuse of the Edinburgh Postnatal Depression Scale. London: Gaskell; 1994;p. 103–111
  100. O’Hara MW, Schlechte JA, Lewis DA, Wright EJ. Prospective study of postpartum blues: biologic and psychosocial factors. Arch. Gen. Psychiatry. 1991;48:801–806
  101. Okano T, Nomura J. Endocrine study of the maternity blues. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1992;16:921–932
  102. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer’s disease in women. Am. J. Epidemiol. 1994;140:256–261
  103. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet. Gynecol. 1992;80:30–36
  104. Parlee MB. Social factors in the psychology of menstruation, birth and menopause. Primary Care. 1976;3:477–490
  105. Paykel ES, Emms EM, Fletcher J, Rassaby ES. Life events and social support in puerperal depression. Br. J. Psychiatry. 1980;136:339–346
  106. Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin reuptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol. Brain Res. 1998;53:120–129
  107. Pedersen CA, Stern RA, Evans DL, Pate J, Jamison C, Ozer H. Natural killer cell activity is lower in postpartum dysphorics. Biol. Psychiatry. 1993;33:85A
  108. Pederson CA, Stern RA, Pate J, Senger MA, Bowes WA, Mason GA. Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum. J. Affect. Disord. 1993;29:201–211
  109. Pop VJM, Essed GG, de Geus CA, vanSon MM, Komproe IH. Prevalence of post partum depression—or is it post-puerperium depression?. Acta Obstet. Gynecol. Scand. 1993;72:354–358
  110. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocr. Rev. 1998;19:397–428
  111. Purnine D, Frank E. Should postpartum mood disorders be given a more prominent or distinctive place in DSM-IV. In:  Widiger TA,  Frances AJ,  Pincus HA,  Ross R,  First MB,  Davis WW editor. DSM-IV Sourcebook. Vol. 2:Washington, DC: American Psychiatric Association; 1996;p. 261–279
  112. Raja SN, Feehan M, Stanton WR, McGee R. Prevalence and correlates of the premenstrual syndrome in adolescence. J. Am. Acad. Child Adolesc. Psychiatry. 1992;31:783–789
  113. Ramcharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women. J. Clin. Epidemiol. 1992;45:377–392
  114. Rapkin AJ. The role of serotonin in premenstrual syndrome. Clin. Obstet. Gynecol. 1992;35:629–636
  115. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Gynecol. 1997;90:709–714
  116. Roca CA, Schmidt PJ, Bloch M, Rubinow DR. Implications of endocrine studies of premenstrual syndrome. Psychiatr. Ann. 1996;26:576–580
  117. Rosenblatt JS, Mayer AD, Giordano AL. Hormonal basis during pregnancy for the onset of maternal behaviour in the rat. Psychoneuroendocrinology. 1988;13:29–46
  118. Rowe T, Sasse V. Androgens and premenstrual symptoms—the response to therapy. In:  Denneerstein L,  Frazer I editor. Hormones and Behaviour. New York: Elsevier; 1986;p. 160–165
  119. Ryan ND, Varma D. Child and adolescent mood disorders—experience with serotonin-based therapies. Biol. Psychiatry. 1998;44:336–340
  120. Schmidt PJ, Purdy RH, Moore PH, Paul SM, Rubinow DR. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J. Clin. Endocrinol. Metab. 1994;79:1256–1260
  121. Schmidt PJ, Grover GN, Roy-Byrne PP, Rubinow DR. Thyroid function in women with premenstrual syndrome. J. Clin. Endocrinol. Metab. 1993;76:671–674
  122. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 1998;338:209–216
  123. Schmidt PJ, Neiman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 2000;183:414–420
  124. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am. J. Psychiatry. 1991;148:844–852
  125. Schneider LS, Small GW, Hamilton SH, Bystnitsky A, Nemenoff CB, Meyers BS. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am. J. Geriatr. Psychiatry. 1997;5:97–106
  126. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J. Affect. Disord. 1988;14:177–187
  127. Sherwin BB. Progestogens used in menopause. Side effects, mood and quality of life. J. Reprod. Med. 1999;44:227–232
  128. Sherwin BB. Can estrogen keep you smart? Evidence from clinical studies. J. Psychiatry Neurosci. 1999;24:315–321
  129. Sherwin BB, Suranyi-Cadotte BE. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol. Psychiatry. 1990;28:339–348
  130. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol. Psychiatry. 1995;38:814–818
  131. Smith R, Cubis J, Brinsmead M, Lewin T, Singh B, Owens P, et al. Mood changes, obstetric experience and alterations in plasma cortisol, beta-endorphin and CRH during pregnancy and the puerperium. J. Psychosom. Res. 1990;34:53–69
  132. Smith SS, Gong QH, Hsu F-C, Markowitz RS, ffrench-Mullen JM, Li X. GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998;392:926–930
  133. Soares C, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double blind, randomized, placebo-controlled trial. Arch. Gen. Psychiatry. 2001;58:529–534
  134. Steege JF, Stout AL, Knight DL, Nemeroff CB. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am. J. Obstet. Gynecol. 1992;167:168–172
  135. Stein G, Marsh A, Morton J. Mental symptoms weight changes and electrolyte excretion in the first post partum week. J. Psychosom. Res. 1981;25:395–408
  136. Steiner M. Perinatal mood disorders: position paper. Psychopharmacol. Bull. 1998;34:301–306
  137. Steiner M, Born L. Advances in the diagnosis and treatment of premenstrual dysphoria. CNS Drugs. 2000;13:286–304
  138. Steiner M, Born L, Marton P. Menarche and mood disorders in adolescence. In:  Steiner M,  Yonkers KA,  Eriksson E editor. Mood Disorders in Women. London: Martin Dunitz; 2000;p. 247–268
  139. Steiner M, Dunn EJ. The psychobiology of female-specific mood disorders. Infertil. Reprod. Med. Clin. N. Am. 1996;7:297–313
  140. Steiner M, Fleming AS, Anderson VN, Monkhouse E, Boulter GE. A psychoneuroendocrine profile for postpartum blues. In:  Dennerstein L,  Fraser I editor. Hormones and Behaviour. Amsterdam: Elsevier; 1986;p. 327–335
  141. Steiner M, LePage P, Dunn E. Serotonin and gender specific psychiatric disorders. Int. J. Psych. Clin. Pract. 1997;1:3–13
  142. Steiner M, Tam WYK. Postpartum depression in relation to other psychiatric disorders. In:  Miller LJ editors. Postpartum Mood Disorders. Washington, DC: American Psychiatric Press; 1999;p. 47–63
  143. Steiner M, Wilkins A. Diagnosis and assessment of premenstrual dysphoria. Psychiatr. Ann. 1996;26:571–575
  144. Steiner M, Yatham LN, Coote M, Wilkins A, Lepage P. Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?. Psychiatry Res. 1999;87:107–115
  145. Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM. Prophylactic lithium in puerperal psychosis. Br. J. Psychiatry. 1991;158:393–397
  146. Stomati M, Genazzani AD, Petraglia F, Genazzani AR. Contraception as prevention and therapy: sex steroids and the brain. Eur. J. Contracept. Reprod. Health Care. 1998;3:21–28
  147. Stowe ZN, Cassarella J, Landry J, Nemeroff CB. Sertraline in the treatment of women with postpartum major depression. Depression. 1995;3:49–55
  148. Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J. Clin. Endocrinol. Metab. 1997;82:1220–1228
  149. Sumner BE, Fink G. The density of 5-hydroxytryptamine2A receptors in forebrain is increased at pro-oestrus in intact female rats. Neurosci. Lett. 1997;234:7–10
  150. Susman EJ, Dorn LD, Chrousos GP. Negative affect and hormone levels in young adolescents: concurrent and predictive perspectives. J. Youth Adolesc. 1991;20:167–190
  151. Tanner JM. In: 2nd Edition. Growth at Adolescence. Oxford: Blackwell Scientific; 1962;
  152. Tanner JM. Earlier maturation in man. Sci. Am. 1968;218:21–27
  153. Tuiten A, Van Honk J, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch. Gen. Psychiatry. 2000;57:149–153
  154. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin releasing hormone gene expression. J. Clin. Invest. 1993;92:1896–1902
  155. Wang M, Seippel L, Purdy RH, Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5-alpha-pregnan-20-one. J. Clin. Endocrinol. Metab. 1996;81:1076–1082
  156. Waring SC, Rocca WA, Petersen RC, O’Brien PC, Tangalos EG, Kokmen E. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology. 1999;52:965–970
  157. Warnock JK, Bundren JC, Morris DW. Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy. Biol. Psychiatry. 1998;43:464–465
  158. Warren MP, Brooks-Gunn J. Mood and behavior at adolescence: evidence for hormonal factors. J. Clin. Endocrinol. Metab. 1989;69:77–83
  159. Weissman MM, Olfson M. Depression in women: implications for health care research. Science. 1995;269:799–801
  160. Whooley MA, Browner WS. Association between depressive symptoms and mortality in older women. Arch. Intern. Med. 1998;158:2129
  161. Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br. Med. J. 1991;303:613–616
  162. Wong M, Thompson TL, Moss RL. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit. Rev. Neurobiol. 1996;10:189–203
  163. World Health Organization. Research on the menopause. World Health Org. Tech. Rep. Ser. 1981;670:3–120
  164. World Health Organization. Mental, behavioral and developmental disorders. In: Tenth Revision of the International Classification of Diseases (ICD-10). Geneva: World Health Organization; 1996;
  165. World Health Organization. Research on the menopause in the 1990s. World Health Organ. Tech. Rep. Ser. 1996;866:1–79
  166. Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, et al. Cognitive function in postmenopausal women treated with Raloxifene. N. Engl. J. Med. 2001;344:1207–1213
  167. Zacharias L, Wurtman RJ. Blindness: its relation to age of menarche. Science. 1964;144:1154–1155
  168. Zweifel JE, O’Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997;22:189–212

PII: S0165-0327(02)00432-9

doi: 10.1016/S0165-0327(02)00432-9

Journal of Affective Disorders
Volume 74, Issue 1 , Pages 67-83 , March 2003

Article Tools